Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Only 1 in 3 heterosexually active adults is aware of HIV PrEP, and this is even lower among Hispanic/Latinx men and...

Study authors from the CDC found that girls in the sub-Saharan country of Namibia are at increased risk for HIV acquisition and also experience...

  • Study authors from the #CDC found that girls in the sub-Saharan country of Namibia are at increased risk for #HIV acquisition and also experience risk factors that make them eligible for HIV infection prevention programs. https://t.co/LhApamDro1 - view on twitter

The case was discovered in...

Rates of sustained viral suppression among people living with HIV were lower than expected, especially among children and...

After the intervention, more patients were correctly prescribed nPEP and more follow-up visits were...

If the FDA authorizes molnupiravir based on the Antimicrobial Drugs Advisory Committee’s recomendation, it would become the first oral COVID-19...

A recent study attributed COVID-19 morbidity and mortality disparities to “upstream issues” such as underlying conditions and lack of access to testing and...

Moderna and Pfizer’s CEOs voice doubt on the current vaccines’ efficacy with the new variant, but are developing prophylaxis vaccines and treatment strategies to...

  • The CEOs of #Moderna and #Pfizer voice doubt on the current vaccines’ efficacy with the #OMICRON variant but are developing prophylaxis #vaccines and treatment strategies to curtail the new strain. https://t.co/cI3botp0yx - view on twitter

While there is much still unknown about the Omicron variant, the World Health Organization says it poses “very high” risk due to its increased...

Merck’s molnupiravir was poised to be the first oral COVID-19 treatment, but updated data shows its efficacy may have been...